Companies: 10,795·Total market cap: $144.5T
BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp.

BCT.TOTSXHealthcare● Active
$4.38
+$0.07(+1.62%)
Market Cap$8250786
P/E Ratio
52W High$49
52W Low$4.13

BriaCell Therapeutics Corp.(BCT.TO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BCT.TO · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-072024-072023-072022-072021-07
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)$0.00B$0.00B$0.00B($0.00B)
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.02B$0.03B$0.02B$0.01B$0.00B
G&A Expenses$0.00B$0.01B$0.01B$0.01B$0.00B
Total Operating Expenses$0.03B$0.03B$0.02B$0.02B$0.01B
Operating Income($0.03B)($0.03B)($0.02B)($0.02B)($0.01B)
Operating Margin %(computed)
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.03B)($0.00B)($0.02B)($0.03B)($0.01B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Net Income($0.03B)($0.00B)($0.02B)($0.03B)($0.01B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-62.95$-43.68$-195.00$-259.50$-467.51
Wtd Avg Shares0.00B0.00B0.00B0.00B0.00B
EBITDA($0.03B)($0.00B)($0.02B)($0.03B)($0.01B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解BriaCell Therapeutics Corp.

关于BriaCell Therapeutics Corp.(BCT.TO)损益表

BriaCell Therapeutics Corp.(BCT.TO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,BCT.TO实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.03B)(净利率—)。

常见问题

BCT.TO · 4 问

BriaCell Therapeutics Corp.(BCT.TO)2025财年营收为$0.00B,同比down—%。

BCT.TO revenueBCT.TO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08